Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial
Title:
Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial
Author:
Mateos, María-Victoria Oriol, Albert Martínez-López, Joaquín Gutiérrez, Norma Teruel, Ana-Isabel de Paz, Raquel García-Laraña, José Bengoechea, Enrique Martín, Alejandro Mediavilla, Joaquín Díaz Palomera, Luis de Arriba, Felipe González, Yolanda Hernández, Jose-Mariano Sureda, Ana Bello, José-Luis Bargay, Joan Peñalver, Francisco-Javier Ribera, José-María Martín-Mateos, María-Luisa García-Sanz, Ramón Cibeira, María-Teresa Ramos, María-Luisa Martín Vidriales, María-Belén Paiva, Bruno Montalbán, María-Angeles Lahuerta, Juan-José Bladé, Joan Miguel, Jesús-Fernando San